Export 165 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
J. Morris K, Uy, R. Adeline Z., Vidoni, E. D., Wilkins, H. M., Archer, A. E., Thyfault, J. P., Miles, J. M., and Burns, J. M., Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease., J Alzheimers Dis, vol. 58, no. 4, pp. 1129-1135, 2017.
K. R. Kadey, Woodard, J. L., Moll, A. C., Nielson, K. A., J Smith, C., Durgerian, S., and Rao, S. M., Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers., J Alzheimers Dis, vol. 81, no. 1, pp. 189-199, 2021.
C. Kaindlstorfer, Jellinger, K. A., Eschlböck, S., Stefanova, N., Weiss, G., and Wenning, G. K., The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint., J Alzheimers Dis, vol. 61, no. 4, pp. 1253-1273, 2018.
C. Kaizik, Caga, J., Camino, J., O'Connor, C. M., McKinnon, C., Oyebode, J. R., Piguet, O., Hodges, J. R., and Mioshi, E., Factors Underpinning Caregiver Burden in Frontotemporal Dementia Differ in Spouses and their Children., J Alzheimers Dis, vol. 56, no. 3, pp. 1109-1117, 2017.
L. Flem Kalheim, Fladby, T., Coello, C., Bjørnerud, A., and Selnes, P., [18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose., J Alzheimers Dis, vol. 62, no. 4, pp. 1595-1607, 2018.
V. Kalia, Kulick, E. R., Vardarajan, B., Gu, Y., Manly, J. J., Elkind, M. S. V., Kaufman, J. D., Jones, D. P., Baccarelli, A. A., Mayeux, R., Kioumourtzoglou, M. - A., and Miller, G. W., Linking Air Pollution Exposure to Blood-Based Metabolic Features in a Community-Based Aging Cohort with and without Dementia., J Alzheimers Dis, vol. 96, no. 3, pp. 1025-1040, 2023.
E. - L. Kallio, Öhman, H., Kautiainen, H., Hietanen, M., and Pitkälä, K., Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 56, no. 4, pp. 1349-1372, 2017.
D. M. Kamara, Gangishetti, U., Gearing, M., Willis-Parker, M., Zhao, L., Hu, W. T., and Walker, L. C., Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 4, pp. 1815-1826, 2018.
Y. Kamikubo, Takasugi, N., Niisato, K., Hashimoto, Y., and Sakurai, T., Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells., J Alzheimers Dis, vol. 56, no. 2, pp. 641-653, 2017.
A. Kaminari, Tsilibary, E. C., and Tzinia, A., A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus., J Alzheimers Dis, vol. 64, no. 1, pp. 1-16, 2018.
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost., J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score., J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
R. Kandimalla and P Reddy, H., Therapeutics of Neurotransmitters in Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 4, pp. 1049-1069, 2017.
S. Kang, Jeong, H., Baek, J. - H., Lee, S. - J., Han, S. - H., Cho, H. Jin, Kim, H., Hong, H. Seok, Kim, Y. Ho, Yi, E. C., Seo, S. Won, Na, D. L., Hwang, D., and Mook-Jung, I., PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1563-76, 2016.
J. Myeong Kang, Yeon, B. Kil, Cho, S. - J., and Suh, Y. - H., Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials., J Alzheimers Dis, vol. 54, no. 3, pp. 879-889, 2016.
K. Kantarci, Lowe, V. J., Lesnick, T. G., Tosakulwong, N., Bailey, K. R., Fields, J. A., Shuster, L. T., Zuk, S. M., Senjem, M. L., Mielke, M. M., Gleason, C., Jack, C. R., Rocca, W. A., and Miller, V. M., Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition., J Alzheimers Dis, vol. 53, no. 2, pp. 547-56, 2016.
M. Kapadia, M Mian, F., Michalski, B., Azam, A. B., Ma, D., Salwierz, P., Christopher, A., Rosa, E., Zovkic, I. B., Forsythe, P., Fahnestock, M., and Sakic, B., Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice., J Alzheimers Dis, vol. 63, no. 3, pp. 1191-1205, 2018.
A. Kapasi, Yu, L., Stewart, C., Schneider, J. A., Bennett, D. A., and Boyle, P. A., Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility., J Alzheimers Dis, vol. 83, no. 2, pp. 879-887, 2021.
D. Kapogiannis and Mattson, M. P., Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease., Lancet Neurol, vol. 10, no. 2, pp. 187-98, 2011.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years., J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
K. Kara, Mahabadi, A. Abbas, Weimar, C., Winkler, A., Neumann, T., Kälsch, H., Dragano, N., Moebus, S., Erbel, R., Jöckel, K. - H., and Jokisch, M., N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population., J Alzheimers Dis, vol. 55, no. 1, pp. 359-369, 2017.
I. Karakis, Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G., DeCarli, C., Vasan, R. S., Wang, T. J., Himali, J. J., Annweiler, C., and Seshadri, S., Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study., J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
A. Karch, Llorens, F., Schmitz, M., Arora, A. Singh, Zafar, S., Lange, P., Schmidt, C., and Zerr, I., Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia., J Alzheimers Dis, vol. 54, no. 4, pp. 1385-1393, 2016.
T. K. Karikari, Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance., J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
R. Karki, Kodamullil, A. Tom, and Hofmann-Apitius, M., Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs., J Alzheimers Dis, vol. 60, no. 2, pp. 721-731, 2017.